Medical Tourism Market by Treatment Type - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403098
  • Report
  • Region: Global
  • 185 pages
  • Allied Analytics LLP
1 of 3
Medical tourism can be defined as an organized travel across international borders with the purpose of availing medical treatment of some form, which may or may not be available in the travelers’ home country. The global medical tourism market accounted for $61,172 million in 2016, and is estimated to reach at $165,345 million by 2023, registering a CAGR of 15.0% from 2017 to 2023.

Medical tourists travel abroad for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities & treatments available in other countries, which are comparatively expensive in their own country. It is also linked with leisure and business travel. Therefore, there are several definitions of medical tourism in the market. Some of them include cosmetic, dental, wellness, and spa services. However, for the purpose of this report, wellness, spa, cosmetic, and dental treatment are excluded from the scope of this study.

Availability of affordable medical care & treatment in developing countries and growth in compliance on international standards drive the market. In addition, availability of latest medical treatments augment market growth. However, limited coverage and lengthy partial reimbursement by payers and epidemic outbreaks restrict the market. Furthermore, wider hospital network under insurance coverage for cashless transaction provides lucrative opportunities to the market players.

The medical tourism market is segmented based treatment type and geography. By treatment type, the market is divided into cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and other treatments. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

This study provides a comprehensive overview of the competitive scenario of the market by profiling key market participants. The service providers profiled in this study include

KEY MARKET BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global medical tourism market and the current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on application assists to understand the trends in the industry.
Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY PLAYERS PROFILED IN THE REPORT

Apollo Hospitals Enterprise Ltd.
Fortis Healthcare Ltd.
Asian Heart Institute and Research Centre Pvt. Ltd.
KPJ Healthcare Berhad
Barbados Fertility Centre
NTT Medical Center Tokyo
Seoul National University Hospital
UZ Leuven (University Hospitals Leuven)
Infectious Diseases Partners Pte. Ltd.
Aditya Birla Memorial Hospital
Prince Court Medical Centre
Samitivej Public Company Limited;

KEY MARKET SEGMENTS

By Treatment Type

Cardiovascular Treatment
Orthopedic Treatment
Neurological Treatment
Cancer Treatment
Fertility Treatment
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Indonesia
Singapore
Malaysia
Thailand
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Venezuela
Costa Rica
UAE
South Africa
Rest of LAMEA

The other players in the value chain include (profiles not included in the report)

Bumrungrad International Hospital
Min-Sheng General Hospital
Raffles Medical Group
Bangkok Hospital Medical Center
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. REIMBURSEMENT SCENARIO

3.3.1. Developed regions
3.3.2. Developing regions

3.4. GOVERNMENT REGULATIONS
3.5. TOP PLAYER POSITIONING (2016)
3.6. PORTERS FIVE FORCES ANALYSIS
3.7. MARKET DYNAMICS

3.7.1. Drivers

3.7.1.1. Affordable good quality care
3.7.1.2. Availability of quality care
3.7.1.3. Accessible information and care
3.7.1.4. Assistance and support from government agencies and associations

3.7.2. Restraints

3.7.2.1. Limited coverage and lengthy partial reimbursement by payers
3.7.2.2. Difficulties associated with travel, language barriers, availability, documentation and VISA approval issues

3.7.1. Opportunities

3.7.1.1. Overseas promotional offices is key sources of medical tourists
3.7.1.2. Wider hospital network under insurance coverage for cashless transactions

CHAPTER 4 MEDICAL TOURISM MARKET, BY TREATMENT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CARDIOVASCULAR TREATMENT

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ORTHOPEDIC TREATMENT

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. NEUROLOGICAL TREATMENT

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. CANCER TREATMENT

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. FERTILITY TREATMENT

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTHER GENERAL TREATMENT

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

CHAPTER 5 MEDICAL TOURISM MARKET, BY GEOGRAPHY

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. India market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. Indonesia market size and forecast
5.4.3.4. Singapore market size and forecast
5.4.3.5. Malaysia market size and forecast
5.4.3.6. Thailand market size and forecast
5.4.3.7. South Korea market size and forecast
5.4.3.8. Taiwan market size and forecast
5.4.3.9. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast
5.5.3.1. Venezuela market size and forecast
5.5.3.1. Costa Rica market size and forecast
5.5.3.1. UAE market size and forecast
5.5.3.1. South Africa market size and forecast
5.5.3.1. Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY/ HOSPITAL PROFILES

6.1. APOLLO HOSPITALS ENTERPRISE LIMITED

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance

6.2. FORTIS HEALTHCARE LIMITED.

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance

6.3. ASIAN HEART INSTITUTE

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Business performance

6.4. KPJ HEALTHCARE BERHAD

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance

6.5. NIT MEDICAL CENTER TOKIO (NMCT)

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance

6.6. SEOUL NATIONAL UNIVERSITY HOSPITAL (SNUH)

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.6.5. Business performance

6.7. UZ LEUVEN

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance

6.8. INFECTIOUS DISEASES PARTNERS PTE LTD (IDPPL)

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance

6.9. ADITYA BIRLA MEMORIAL HOSPITAL (ABMH)

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance

6.10. BARBADOS FERTILITY CENTRE (BFC)

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance

6.11. PRINCE COURT MEDICAL CENTRE (PCMC)

6.11.1. Company overview
6.11.2. Company snapshot
6.11.3. Operating business segments
6.11.4. Product portfolio
6.11.5. Business performance

6.12. SAMITIVEG PUBLIC COMPANY LIMITED (SPCL)

6.12.1. Company overview
6.12.2. Company snapshot
6.12.3. Operating business segments
6.12.4. Product portfolio
6.12.5. Business performance
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll